2012 IMPACT Symposium II - Speakers

"Clinical Trials in the Era of Personalized Medicine"tunnel


Home   Agenda   Speakers   Workshop Slides

Daniel Almirall, PhD, Faculty Research Fellow, Institute of Social Research, University of Michigan "Getting SMART about developing individualized sequences of health interventions" [Abstract]

Georgiy Bobashev, PhD, Senior Research Statistician, RTI International "Prediction of the Best Treatment Assignment Using Random Forest with Regression in the Nodes" [Abstract]

William Carpenter, PhD Assistant Professor, UNC-Chapel Hill Department of Health Policy and Management "Data needs for cancer comparative effectiveness research, and the Integrated Cancer and Surveillance System" [Abstract]

Shein-Chung Chow, PhD, Professor, Duke University Department of Biostatistics and Bioinformatics and Professor of Clinical Sciences, Duke-NUS Graduate Medical School in Singapore "Benefits, Challenges, and Obstacles of Adaptive Clinical Trial Designs" [Abstract]

Constantine Gatsonis, PhD, Henry Ledyard Goddard University Professor of Biostatistics, Chair of the Department of Biostatistics, and Director of the Center for Statistical Sciences, Brown University "Clinical Evaluation of Diagnostic Tests and Biomarkers in CER" [Abstract]

Anastasia Ivanova, PhD Associate Professor, UNC-Chapel Hill Department of Biostatistics "Oncology phase II trials with ordinal outcome" [Abstract]

Kristin Linn, PhD Student, NCSU Department of Statistics "IQ-Learning" [Abstract]

Howard L. McLeod, PharmD, Fred Eshelman Distinguished Professor of Pharmacogenomics and Individualized Therapy, UNC Eshelman School of Pharmacy and Director, Institute for Pharmacegenomics and Individualizes Therapy, UNC-Chapel Hill "Pharmacogenomics: discovery is necessary, but not sufficient" [Abstract]

Susan A. Murphy, PhD, H.E. Robbins Professor of Statistics & Professor of Psychiatry, and Research Professor, Institute for Social Research, University of Michigan "Getting SMART about developing individualized sequences of health interventions" [Abstract]

Kouros Owzar, PhD, Assistant Professor, Duke University Department of Biostatistics and Bioinformatics "Challenges in genome-wide association analysis of drug-induced toxicity data from clinical trials" [Abstract]

Daniel J. Sargent, PhD, Professor of Biostatistics and Professor of Oncology, Mayo Clinic "Biomarker-based clinical trials" [Abstract]

Richard Simon, PhD, Chief, Biometric Research Branch, National Cancer Institute "Development of Predictive Biomarkers for Targeted Therapies" [Abstract]

Rui Song, PhD, Assistant Professor, NCSU Department of Statistics "Penalized Q-Learning for Dynamic Treatment Regimes" [Abstract]